Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Anika Therapeutics, Inc.
Company plans to file premarket approval application for CTA product
June 15th, 2005
Anika Therapeutics, Inc., (ANIK) announced that it intends to file a pre-market approval (PMA) application with the U.S. Food and Drug Administration for its cosmetic tissue augmentation (CTA) product. "We have completed our preliminary review of the results of our CTA clinical trial and, based on those results, intend to move forward with filing a PMA by the end of the third quarter," said Charles Sherwood, PhD, president and chief executive officer. Headquartered in Woburn, Massachusetts, Anika Therapeutics develops, manufactures and commercializes therapeutic products and devices intended to promote the repair, protection and healing of bone,...
Source: Physician Law Weekly (2005-06-15)
|
